# OnCo record secondary-brain-tumours (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/secondary-brain-tumours/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "secondary-brain-tumours" ;
  schema:name "Brain metastases (secondary brain tumours)"@en ;
  schema:alternateName "Brain metastases"@en, "Secondary brain cancer"@en, "Intracranial metastases"@en, "Cerebral metastases"@en, "Brain mets"@en ;
  schema:description "Brain metastases are cancers that have spread to the brain from elsewhere, most often from the lung, breast or skin. Focused radiation aimed at each spot (radiosurgery) has largely replaced radiation to the whole brain, and for some cancers modern targeted drugs and immunotherapy reach the brain well enough to shrink the deposits on their own."@en ;
  schema:url <https://onco.cc/cancers/secondary-brain-tumours/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Brain_metastasis> ;
  schema:citation <https://en.wikipedia.org/wiki/Brain_metastasis>, <https://doi.org/10.1001/jama.2016.9839>, <https://doi.org/10.1016/S0140-6736(16)30825-X> ;
  onco:tag "subtype-page", "cns" ;
  onco:related <https://onco.cc/cancers/brain-tumours/>, <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/radiosurgery-srs/>, <https://onco.cc/technologies/gamma-knife/>, <https://onco.cc/technologies/cyberknife/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/bbb-focused-ultrasound/> ;
  onco:drugs <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/osimertinib/>, <https://onco.cc/drugs/lorlatinib/>, <https://onco.cc/drugs/alectinib/>, <https://onco.cc/drugs/tucatinib/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/dabrafenib-trametinib/> ;
  onco:terms <https://onco.cc/terms/brain-metastases/>, <https://onco.cc/terms/wbrt/>, <https://onco.cc/terms/stereotactic-radiosurgery/>, <https://onco.cc/terms/blood-brain-barrier/>, <https://onco.cc/terms/her2-brain-metastases/>, <https://onco.cc/terms/leptomeningeal-disease/> ;
  onco:trials <https://onco.cc/trials/alliance-n0574/>, <https://onco.cc/trials/nrg-cc001/>, <https://onco.cc/trials/quartz/>, <https://onco.cc/trials/her2climb/>, <https://onco.cc/trials/destiny-breast12/>, <https://onco.cc/trials/crown/> ;
  onco:pipeline <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/drugs/tucatinib/>, <https://onco.cc/drugs/lorlatinib/>, <https://onco.cc/technologies/bbb-focused-ultrasound/>, <https://onco.cc/technologies/radiosurgery-srs/> ;
  onco:standardOfCare <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/technologies/radiosurgery-srs/>, <https://onco.cc/technologies/radiosurgery-srs/>, <https://onco.cc/technologies/gamma-knife/>, <https://onco.cc/technologies/cyberknife/>, <https://onco.cc/trials/alliance-n0574/>, <https://onco.cc/terms/wbrt/>, <https://onco.cc/trials/nrg-cc001/>, <https://onco.cc/trials/quartz/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/osimertinib/>, <https://onco.cc/drugs/lorlatinib/>, <https://onco.cc/drugs/alectinib/>, <https://onco.cc/trials/crown/>, <https://onco.cc/drugs/tucatinib/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/trials/her2climb/>, <https://onco.cc/trials/destiny-breast12/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/dabrafenib-trametinib/>, <https://onco.cc/technologies/radiosurgery-srs/> .